Status not kept up to date
Robotic Enhanced Error Training of Upper Limb Function in Post-stroke Patients
NCT05174676 · Reuth Rehabilitation Hospital · Updated 4 Jan 2022
- What is being tested
- Dextreme
- For
- CVA (Cerebrovascular Accident); Paresis
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 40 people. The full rules are on the registry page.
- Where
- Israel
- When
- Starts or started 20 Dec 2021, ends Dec 2022. Registered 3 Jan 2022.
- Results
- None posted yet.
In the researchers' words
Background: Stroke is a common cause of morbidity, including paresis, and stroke survivors often have reduced function in their paretic arm. Many do not regain full recovery of their arm function, which negatively impacts their quality of life. Recent studies have indicated that robotic training may improve upper limb function abilities among stroke survivors, by enabling repetitive, adaptive, and intensive training and more accurate control of task complexity. Robotic training in addition to standard rehabilitative care has shown promise for improving functional skills among stroke survivors. One type of robotic training is error enhancement, whereby an error made by the patient is exaggerated, increasing the signal to noise ratio which causes errors to be more noticeable. This, in turn, enhances movement correction. Previous studies have found that error enhancement has promise as a clinical treatment for patients with motor deficits. Objectives: This study aims to evaluate the effect of a robotic device (DeXtreme) on the functional capabilities of the paretic arm of stroke survivors. This device aims to improve arm function by utilizing error enhancement techniques. Methods: A double-blind randomized placebo-controlled study comparing treatment outcomes between two groups to assess the effect of error enhancement robotic training on functional use of the arm and hand in…
Sites
- Reuth Rehabilitation HospitalTel Aviv, Israel
